RDY — Dr Reddy's Laboratories Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Dr Reddy's Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	23,358	18,857	28,835	30,614	60,485
Depreciation
Non-Cash Items	-2,998	13,994	8,584	7,102	4,457
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-3,004	-14,641	-14,004	-21,260	-18,569
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	28,704	29,841	35,703	28,108	58,875
Capital Expenditures	-8,376	-6,115	-12,561	-19,049	-18,866
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	649	1,192	-10,099	-7,338	-22,507
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-7,727	-4,923	-22,660	-26,387	-41,373
Financing Cash Flow Items	-1,607	-1,608	-1,321	-1,345	-1,853
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-21,326	-25,159	-298	-2,422	-26,861
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-314	-266	12,858	32	-9,073